Billionaire-backed Juvenescence primes the anti-aging pipeline pump with a $12M seed round
Juvenescence CEO Greg Bailey told me back in July that he expected he would have to raise hundreds of millions of dollars to push the pipeline of anti-aging remedies he planned to create. But he’s starting on a much more modest level.
The biotech, backed by some well recognized names including UK billionaire Jim Mellon, announced that they have put together their first seed round of $12.3 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.